Babesia Microti, Babesia Burgdorferi Nosode, Borrelia Burgdorferi Nosode Dna,
Generic Name: babesia microti, babesia burgdorferi nosode, borrelia burgdorferi nosode dna,
Dosage form: LIQUID. Active ingredients: BABESIA MICROTI (1 [hp_M]/mL); BORRELIA BURGDORFERI (1 [hp_M]/mL); HERRING SPERM DNA (1 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: BABESIA MICROTI (1 [hp_M]/mL); BORRELIA BURGDORFERI (1 [hp_M]/mL); HERRING SPERM DNA (1 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant
human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL). Category: BLA.
Cetirizine Hydrochloride Tablet, Film Coated
cetirizine hydrochloride tablet, film coated
Purpose Purpose Antihistamine
Dezocine
dezocine
Manufactured by ASTRAZENECA. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DEZOCINE (5MG/ML). Application: NDA019082.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.